WO1993009237A1 - Mais tres sucre et ameliore - Google Patents
Mais tres sucre et ameliore Download PDFInfo
- Publication number
- WO1993009237A1 WO1993009237A1 PCT/EP1992/002531 EP9202531W WO9309237A1 WO 1993009237 A1 WO1993009237 A1 WO 1993009237A1 EP 9202531 W EP9202531 W EP 9202531W WO 9309237 A1 WO9309237 A1 WO 9309237A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- corn
- promoter
- supersweet
- dna
- adp
- Prior art date
Links
- 235000002017 Zea mays subsp mays Nutrition 0.000 title claims description 119
- 240000008042 Zea mays Species 0.000 title claims description 97
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 title claims description 61
- 235000005822 corn Nutrition 0.000 title claims description 61
- 230000001976 improved effect Effects 0.000 title abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 86
- 241000482268 Zea mays subsp. mays Species 0.000 claims abstract description 31
- 230000001939 inductive effect Effects 0.000 claims abstract description 27
- 230000003111 delayed effect Effects 0.000 claims abstract description 22
- 238000013518 transcription Methods 0.000 claims abstract description 17
- 230000035897 transcription Effects 0.000 claims abstract description 17
- 230000010152 pollination Effects 0.000 claims abstract description 16
- 230000000692 anti-sense effect Effects 0.000 claims abstract description 15
- 235000013305 food Nutrition 0.000 claims abstract description 14
- 230000021759 endosperm development Effects 0.000 claims abstract description 9
- 241001057636 Dracaena deremensis Species 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 32
- 230000000694 effects Effects 0.000 claims description 28
- 102000004169 proteins and genes Human genes 0.000 claims description 25
- 108700023224 Glucose-1-phosphate adenylyltransferases Proteins 0.000 claims description 24
- 230000014509 gene expression Effects 0.000 claims description 19
- 108020004414 DNA Proteins 0.000 claims description 17
- 239000013598 vector Substances 0.000 claims description 17
- 239000000411 inducer Substances 0.000 claims description 11
- 230000009466 transformation Effects 0.000 claims description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 9
- 238000003306 harvesting Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 108020004491 Antisense DNA Proteins 0.000 claims description 5
- 239000003816 antisense DNA Substances 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 3
- 108091026890 Coding region Proteins 0.000 claims description 2
- 101710166809 ADP-glucose phosphorylase Proteins 0.000 claims 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 16
- 238000003786 synthesis reaction Methods 0.000 abstract description 14
- 241000196324 Embryophyta Species 0.000 description 43
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 30
- 235000009973 maize Nutrition 0.000 description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 210000004027 cell Anatomy 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 23
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 22
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- 229920002472 Starch Polymers 0.000 description 21
- 235000019698 starch Nutrition 0.000 description 21
- 239000008107 starch Substances 0.000 description 21
- 108020004999 messenger RNA Proteins 0.000 description 19
- 239000002689 soil Substances 0.000 description 15
- 239000002299 complementary DNA Substances 0.000 description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
- 239000013612 plasmid Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 10
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 10
- UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 206010020649 Hyperkeratosis Diseases 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000009418 agronomic effect Effects 0.000 description 9
- 150000002061 ecdysteroids Chemical class 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 238000003556 assay Methods 0.000 description 8
- 102000005962 receptors Human genes 0.000 description 8
- 108020003175 receptors Proteins 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 210000002729 polyribosome Anatomy 0.000 description 7
- 101001036768 Zea mays Glucose-1-phosphate adenylyltransferase large subunit 1, chloroplastic/amyloplastic Proteins 0.000 description 6
- 239000000556 agonist Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 150000003431 steroids Chemical class 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 108020004635 Complementary DNA Proteins 0.000 description 5
- PJYYBCXMCWDUAZ-YKDQUOQBSA-N Ponasterone A Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@@](O)([C@@H](O)CCC(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 PJYYBCXMCWDUAZ-YKDQUOQBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 235000007244 Zea mays Nutrition 0.000 description 5
- 230000035508 accumulation Effects 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 238000002955 isolation Methods 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- PJYYBCXMCWDUAZ-JJJZTNILSA-N 2,3,14,20,22-pentahydroxy-(2β,3β,5β,22R)-Cholest-7-en-6-one Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 PJYYBCXMCWDUAZ-JJJZTNILSA-N 0.000 description 4
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 4
- 108010055615 Zein Proteins 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 3
- WFPZSXYXPSUOPY-ROYWQJLOSA-N ADP alpha-D-glucoside Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WFPZSXYXPSUOPY-ROYWQJLOSA-N 0.000 description 3
- WFPZSXYXPSUOPY-UHFFFAOYSA-N ADP-mannose Natural products C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COP(O)(=O)OP(O)(=O)OC1OC(CO)C(O)C(O)C1O WFPZSXYXPSUOPY-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010070675 Glutathione transferase Proteins 0.000 description 3
- 102000005720 Glutathione transferase Human genes 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 238000000636 Northern blotting Methods 0.000 description 3
- 108091027981 Response element Proteins 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920002494 Zein Polymers 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 3
- 102000023732 binding proteins Human genes 0.000 description 3
- 108091008324 binding proteins Proteins 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 108020001507 fusion proteins Proteins 0.000 description 3
- 102000037865 fusion proteins Human genes 0.000 description 3
- 230000035784 germination Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 102000005969 steroid hormone receptors Human genes 0.000 description 3
- 108020003113 steroid hormone receptors Proteins 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000005019 zein Substances 0.000 description 3
- 229940093612 zein Drugs 0.000 description 3
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 2
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 2
- 108090000190 Thrombin Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000012411 cloning technique Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 108010057988 ecdysone receptor Proteins 0.000 description 2
- 108010010918 ecdysteroid receptor Proteins 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 108010050792 glutenin Proteins 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- RSZXXBTXZJGELH-UHFFFAOYSA-N 2,3,4-tri(propan-2-yl)naphthalene-1-sulfonic acid Chemical compound C1=CC=CC2=C(C(C)C)C(C(C)C)=C(C(C)C)C(S(O)(=O)=O)=C21 RSZXXBTXZJGELH-UHFFFAOYSA-N 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- 108010000700 Acetolactate synthase Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- 241000042795 Colotes Species 0.000 description 1
- 239000005504 Dicamba Substances 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 101150007068 HSP81-1 gene Proteins 0.000 description 1
- 101150087422 HSP82 gene Proteins 0.000 description 1
- 101150028525 Hsp83 gene Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 101100070542 Podospora anserina het-s gene Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- HXXFSFRBOHSIMQ-VFUOTHLCSA-N alpha-D-glucose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-VFUOTHLCSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- IWEDIXLBFLAXBO-UHFFFAOYSA-N dicamba Chemical compound COC1=C(Cl)C=CC(Cl)=C1C(O)=O IWEDIXLBFLAXBO-UHFFFAOYSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229950010772 glucose-1-phosphate Drugs 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Substances NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002428 insect molting hormone Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000002949 juvenile hormone Substances 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 102000003998 progesterone receptors Human genes 0.000 description 1
- 108090000468 progesterone receptors Proteins 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- 230000030118 somatic embryogenesis Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 108050000156 vitamin D receptors Proteins 0.000 description 1
- 102000009310 vitamin D receptors Human genes 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
Definitions
- This invention relates to plant biotechnology and specifically to corn, alternatively novn as maize, Zea mays or Indian corn.
- the invention relates to supersweet corn with improved qualities, methods of producing the improved supersweet corn, vectors for the genetic engineering of the corn, DNA used to transform corn, and genomic clones containing the desired DNA.
- the endosperm is a major site of starch deposition during maize kernel development. Many genetic loci affecting carbohydrate metabolism are known and some have been biochemically characterized. When some of these genes are not expressed, the result is generally a decrease in starch biosynthesis and a concomitant accumulation of sucrose to give a seed product commonly referred to as sweet corn and used as a human food product. Corn in which the levels of starch biosynthesis are normal is commonly referred to as field corn, and is often used for animal feed.
- Su Sud-1
- Sh-2 shrunken-2
- Bt-2 brittle-2
- Sweet corn results from the presence of a homozygous recessive allele at the sugary-1 locus on chromosome 4, designated su. When su is present, there is a 3-5 fold increase in the percentage of sucrose (dry weight) relative to wild-type Su lines.
- the Sh-2 and Bt-2 genes, both involved in starch production, encode subunits of the enzyme ADP-glucose pyrophosphorylase (ADP-GPP) ( ⁇ _D-glucose-l-phosphate adenyl transferase, EC 2.7.7.27).
- ADP-GPP ADP-glucose pyrophosphorylase
- ADP-GPP catalyzes the reversible synthesis of ADP-glucose and pyrophosphate from ATP and glucose-1-phosphate. The equilibrium constant for this reaction is unity and the reaction is driven by pyrophosphate hydrolysis.
- ADP-glucose is the glucosyl donor for starch chain elongation catalysed by starch synthetase.
- ADP-GPP is made up of four subunits: two subunits of a 60 kDa polypeptide encoded by the Sh-2 gene (hereinafter referred to as the Sh-2 gene), and two subunits of a 55 kDa polypeptide encoded by the Bt-2 gene (hereinafter referred to as the Bt-2 protein).
- the 60 kDa or the 55 kDa subunits are not properly synthesized, and little or no functional ADP-GPP is made.
- starch synthesis is impaired, sucrose accumulates to 2-4 times the levels of normal sweet corn, and the corn is "supersweet".
- supersweet corn which, when harvested for food at approximately 77% moisture content, typically about 19-21 days after pollination, has high sugar and low starch for flavour but has mature kernels at approximately 30-35% moisture content, about 55 days after pollination, with a starchy field corn like endosperm for ease of seed processing, improved germination and disease resistance. No such supersweet corn is currently available.
- European patent application EP 0 368 506 discloses a plant having enhanced ability to produce starch comprising a starch synthesizing plant having stably incorporated within its genome by transformation of one or more than one additional copy of a gene encoding ADP-glucose pyrophosphorylase.
- International patent application WO 91/19806 concerns a method for increasing the starch content of a plant which comprises altering said plant to increase the ADP glucose pyrophosphorylase activity in said plant.
- EP 0455 316 concerns plasmids which may be used to increase or decrease protein concentration or to both reduce starch concentration and increase saccharide concentration in plant cells, for instance by decreasing ADP-GPP activity.
- IGFB European patent application EP 0455 316
- This invention provides corn with improved kernel characteristics such that when harvested for food it has "supersweet” taste, but when harvested for seed, it has starchy kernels similar to those of field corn.
- this invention provides supersweet corn which has been genetically modified to express ADP-glucose pyrophophorylase activity at approximately 25-30 days post pollination.
- the invention includes genetically modified corn plants, and propagatable parts thereof including cells and tissue, and seeds, and progeny thereof including hybrid progeny thereof.
- this aspect of the invention includes supersweet corn which is homozygous recessive sh-2 and contains within its genome a functional Sh-2 structural gene under the control of a heterologous promoter.
- this aspect also includes supersweet corn which is homozygous recessive bt-2 and contains within its genome a functional Bt-2 structural gene under the control of a heterologous promoter.
- this aspect also includes supersweet corn which is sh-2 and/or bt-2 homozygous recessive and contains within its genome a functional Sh-2 gene under the control of a heterologous promoter and a functional Bt-2 gene under the control of a heterologous promoter.
- the heterologous promoters used in the above embodiments of the invention may comprise developme tally delayed promoters such that the Sh-2 gene and/or Bt-2 gene does not begin to be expressed until 20 to 25 days post pollination.
- Such corn plants are phenotypically characterized by having supersweet corn kernels at the time at harvest for food but have kernels which resemble the starchy kernels of field corn when harvested later for seed production.
- heterologous promoters used in this aspect of the invention may comprise inducible promoters.
- inducible promoters if the plant is grown for its seed crop, it is exposed to the inducer and starch synthesis takes place. If grown for a food crop, the plant is not exposed to the inducer, so very little, if any starch synthesis takes place and the kernels are supersweet.
- the invention also provides sweet corn which has been genetically modified by inclusion of anti-sense DNA the transcription of which is regulated or regulatable such that expression of ADP-glucose pyrophosphorylase activity is or can be inhibited until at least 25 to 30 days post pollination.
- the sweet corn contains within its genome anti-sense Sh-2 DNA under the control of a heterologous promoter or/and anti-sense Bt-2 DNA under the control of a heterologous promoter.
- the heterologous promoters used may comprise inducible promoters, such that when the plant is exposed to the inducer anti-sense DNA is transcribed and blocks expression of ADP-GPP activity resulting in supersweet corn kernels. If no inducer is used with such inducible promoters, normal sweet corn results which may be harvested for food or seed as is customary for normal sweet corn. When an inducer is used the resulting supersweet corn is preferably harversted for food and is not grown on for seed harvest.
- the promoters used in this further aspect may comprise a promoter which is active in early endosperm development, i.e. a promoter which is active during the period up to 25 to 30 days post pollination.
- promoters include natural endosperm promoters which are active early in endosperm development.
- synthetic promoters which function as early active endosperm promoters may be used.
- a natural or synthetic constitutive promoter element which has been manipulated to contain an early active endosperm promoter element and which is operatively linked to an element which confers endosperm activity may be used.
- the invention provides a DNA expression cassette comprising a protein coding DNA sequence and a promoter wherein the DNA sequence comprises DNA coding for a corn ADP-GPP subunit (e.g. Sh-2 or Bt-2) or a functional part thereof or a DNA sequence which hybridises therewith under stringent hybridisation conditions and which codes for a protein, having the activity of an ADP-GPP subunit i.e. a protein, having ADP-GPP subunit activity, and the promoter comprises a developmentally delayed promoter or an inducible promoter.
- a corn ADP-GPP subunit e.g. Sh-2 or Bt-2
- the promoter comprises a developmentally delayed promoter or an inducible promoter.
- the invention also provides a DNA transcription cassette comprising an anti-sense DNA sequence complementary to a DNA sequence which codes for a peptide having ADP-GPP subunit activity, and an inducible promoter or a promoter which is active in early endosperm development.
- the invention includes vectors containing the DNA expression or transcription cassettes, processes for transforming corn with the cassettes or vectors and corn plants and parts thereof (tissue and cells) transformed with the cassettes or vectors.
- the invention also includes cultivation processes in which genetically modified supersweet corn or sweet corn according to the invention in which inducible promoters are used, is cultivated and exposed to a corresponding inducer as required for food or seed harvest.
- the invention includes genomic clones of Sh-2 and Bt-2.
- the invention includes the genomic clone of Sh-2 contained in plasmid pZ01300 and the genomic clone of Bt-2 contained in plasmid pZ01301, which were deposited at the American Type Culture Collection on 2 October 1991 under accession numbers 75129 and 75130 respectively, and parts variants and analogues thereof.
- the invention includes the Sh-2 genomic DNA sequence as set out in the Sequence listing as SEQ ID N0:1 and parts, variants and analogues thereof. Applicants hereby indicate that they elect the "expert solution" as regards availability of the above deposits during pendency of the EPC patent application designated herein, under the provisions of Rule 28 (4) EPC.
- “Sweet corn” means Zea mays in which the genes at the sugary-1 locus are in the homozygous recessive condition.
- Supersweet corn means Zea mays in which the shrunken-2 and/or brittle-2 genes are in the homozygous recessive condition.
- Heterologous promoter means a promoter which does not naturally control expression of its associated structural gene, although the promoter may be of Zea mays origin.
- sh-2 refers to a recessive shrunken-2 gene.
- sh-2 When both copies of the shrunken-2 gene are recessive (sh-2), the result is supersweet corn.
- B-2 refers to the wild-type brittle-2 gene.
- bt-2 refers to the recessive brittle-2 gene.
- bt-2 recessive
- Dpp days post pollination
- the time of "harvest for food” is generally that time when kernel moisture content is approximately 77%. Under typical environmental growing conditions, this is generally 19-21 dpp.
- the time of "harvest for seed crop” is generally that time when the kernel moisture content is approximately 30-35%. Under optimal environmental growing conditions, this is approxmately 55 dpp.
- “Stringent hybridisation conditions” as used throughout the specification and claims are those in which hybridisation is effected in a standard manner at 65°C in 4X buffered saline (a.k.a. SSPE buffer) followed by merely washing at 57°C in 0.2X SSPE, which will not affect true duplexes which have formed.
- Figure 1 shows the Northern blot for Sh-2 mRNA in two corn lines, a regular sweet corn hybrid "201 X 202" (su Sh-2) and a supersweet inbred "101" (Su sh-2).
- the probe used is [32P]-Sh-2 cDNA.
- Lanes 1-5 are “201 X 202" and lane 6 is "101”.
- Lane 1 shows 2.5 ⁇ g endosperm bound polysomal RNA at 25 dpp; Lane 2 shows 2.5 ⁇ g free polysomal RNA at 25 dpp; Lane 3 shows 10 ⁇ g total endosperm RNA at 25 dpp; Lane 4 is 10 ⁇ g leaf total RNA; Lane 5 is 10 ⁇ g root RNA; Lane 6 is 10 ⁇ g total endosperm RNA 21 dpp.
- Figure 2 is the same blot as in Figure 1 after it is stripped and subsequently probed with [32P]-labelled Bt-2 cDNA.
- Figure 3 is a graph showing the developmental profile of both polysomal and total Bt-2 RNA.
- Figure 4 is a graph showing the developmental profile of both polysomal and total Sh-2 RNA.
- Figure 5 is a composite restriction map of the Sh-2 genomic clone.
- Figure 6 is a restriction map of the Bt-2 genomic clone.
- Figure 7 is a graph of ADP glucose pyrophosphorylase activity of anti-sense transformants. 17.5 ⁇ g of total soluble cellular protein was added to each assay. The assay is coupled to NAPDH reduction and absorbance at 340 n is measured. The various aspects of the invention identified above are now described in greater detail.
- One approach to modifying supersweet corn so that it retains a high sucrose concentration when harvested for food, but whose seed crop is starchy is to transfer either the Sh-2 structural gene into a homozygous sh-2 plant and/or a Bt-2 structural gene into a homozygous bt-2 plant under the control of a promoter which does not engender transcription until after harvest of the food crop.
- These promoters collectively referred to as “developmentally delayed " " promoters, normally control synthesis of mRNAs that appear late in the development of endosperm.
- Such promoters may be detected in an assay utilizing identifiable markers (such as GUS) operably linked to the putative promoter and assayed in endosperm tissue.
- the developmentally delayed promoter does not become active in endosperm tissue until after about 20 days post pollination (dpp).
- dpp days post pollination
- the optimum promoter for a given heterologous gene may depend on characteristics of the given gene, but should be chosen so that maximum expression and/or gene product accumulation occurs at 25-30 dpp.
- Developmentally delayed promoters may be obtained using the procedures described herein.
- Sh-2 and Bt-2 protein accumulations are also measured as a confirmation of the above finding.
- Anti-sera are made to both Sh-2 and Bt-2 proteins. Protein is isolated from the endosperm at different times post-pollination and is electrophoretically separated and blotted onto a nitrocellulose filter. The filters are probed using the appropriate anti-serum and an antibody sandwich assay is used to visualize the band. The binding is quantified, and is found to confirm the above findings.
- this invention also includes plants transformed with both the Sh-2 and Bt-2 genes, said genes each under the control of a heterologous promoter, and preferably each under the control of a different heterologous promoter.
- a modified subtractive technique strategy may also be used.
- double stranded cDNA from a particular time point is made blunt-ended and linkers are added.
- the linkers serve as a PCR oligomer binding site.
- the cDNA is then amplified prior to cloning and can be used as a probe as well.
- This technique allows identification of clones which have either qualitative or quantitative differences between two different mRNA populations.
- Two developmentally delayed promoters are isolated, one which directs transcription beginning at approximately 20 dpp, hereinafter referred to as Promoter 20, and one which initiates transcription at approximately 25 dpp, hereinafter referred to as Promoter 25.
- Genomic clones of Sh-2 and Bt-2 are made using a genomic library of maize inbred line W22 and Lambda EMBL3.
- W22 is a publicly available line which can be obtained from Maize Cooperative, Stock Center, Univ. Missouri, Columbia, Missouri).
- the genomic clones are screened using cDNA of Sh-2 or Bt-2. Two clones are isolated for Sh-2, shown in Figure 5. A single clone is isolated for Bt-2, and this appears in Figure 6.
- the genomic clones for Bt-2 and for Sh-2 comprise another aspect of this invention.
- Sh-2 genomic clones were difficult, as standard sub-cloning techniques did not readily produce the desired subclones. Surprisingly it was found that the Sh-2 gene contains a sequence which interferes with plasmid replication.
- One technique which successfully produced clones, albeit at a low level (approximately 1% of the expected level) was a three-way ligation.
- One aliquot of vector carrying Sh-2 sequences was cut in its ampicillin resistance (ampr) gene with Seal and in its polylinker with BamHI. A second aliquot was cut with Seal and Sail.
- constructs may be assembled: Promoter 20-Sh-2 and Promoter 25-Bt-2.
- constructs and other constructs which include other preferred developmentally delayed promoters operably linked to either the Sh-2 or the Bt-2 structural gene are specific embodiments of this invention.
- an alternative approach is to place the Sh-2 and/or Bt-2 genes under the control of a promoter which is not developmentally regulated, but is inducible chemically.
- a preferred class of inducible promoters are steroid responsive promoters. Gene expression activation by steroids such as ecdysteroid-like molecules occurs via ligand binding to protein receptors which are members of the steroid receptor superfamily. The steroid ligand binds to its cognate receptor altering receptor conformation, and the resultant binary complex recognises and binds to a steroid response element (SRE) present in the promoter to modulate transcription.
- SRE steroid response element
- the plant cell is transformed with genes encoding both the receptor and the the desired gene operably linked with a steroid responsive promoter, i.e. a natural or constructed promoter comprising an SRE.
- a steroid responsive promoter i.e. a natural or constructed promoter comprising an SRE.
- promoters include those which are responsive to the estrogen/ estrogen receptor, progesterone/ progesterone receptor, vitamin D/ vitamin D receptor and dexamethasone/ glucocortocoid receptor complexes.
- Preferred promoter are those which are responsive to the invertebrate molting hormone, 20-hydroxyecdysone (20-0HE) / receptor complex, which can be induced by the agonist compound l,2-dibenzoyl,l-tert-butyl hydrazine.
- the corn plant is transformed with two constructs: 1) the inducible promoter Sh-2 and/or Bt-2 construct and 2) a receptor for the inducer. Shortly before or after pollination the transformed corn is exposed to the chemical inducer. Transcription of the Sh-2 and/or Bt-2 gene is then initiated, leading to kernels with starchy endosperms. If the plant is transformed with both the Sh-2 and Bt-2 structural genes, both genes may be under the control of an inducible promoter, preferably a part of a ecdysteroid system.
- EcRB ecdysteroid binding protein
- Plants which are transformed with an inducible promoter do not exhibit substantial ADP-GPP activity until presented with the inducer, . after which starch synthesis and starch accumulation occurs.
- the progeny of these plants (either inbred or the result of a cross with a non-related, transformed or non-transformed plant) inducibly express the starchy phenotype. All of these progeny plants are included within the invention.
- an anti-sense transcription construct can be used to regulate starch synthesis.
- the Sh-2 gene or the Sh-2 cDNA in its anti-sense configuration is placed under the control of an inducible promoter, such as those described above or an endosperm promoter active early in endosperm development.
- an inducible promoter such as those described above or an endosperm promoter active early in endosperm development.
- a synthetic promoter can be made which contains an early active endosperm promoter element operatively linked to an element which confers endosperm activity.
- promoters which contain early active endosperm elements include 1) various zein promoters, such as the promoter for gamma, beta or alpha zein; 2) a 198 base pair portion of the low molecular weight glutenin (LMWG) promoter (as in Colot et al, 1987 EMBO J. 6(12):355-359, which is hereby incorporated by reference); and 3) a 227 base pair portion of the high molecular weight wheat glutenin (HMWG) promoter (as in Thomas and Flavell The Plant Cell 2:1171, which is hereby incorporated by reference).
- LMWG low molecular weight glutenin
- HMWG high molecular weight wheat glutenin
- the aforementioned elements may be operatively linked to a normally constitutive promoter element such as the minimal 35S promoter (i.e. comprising the -46 base pair upstream region) or the minimal HSP82 promoter, such as described in co-pending application serial number 07/791,921 which is incorporated by reference.
- a normally constitutive promoter element such as the minimal 35S promoter (i.e. comprising the -46 base pair upstream region) or the minimal HSP82 promoter, such as described in co-pending application serial number 07/791,921 which is incorporated by reference.
- a normal sweet corn plant (su Sh-2) is transformed with one of the aforementioned constructs.
- anti-sense Sh-2 mRNA is transcribed which hybridizes with the wild type Sh-2 mRNA, thereby blocking synthesis of the Sh-2 protein. Consequently, starch synthesis is impaired and sucrose accumulates.
- this anti-sense approach can also be used with the Bt-2 gene.
- the promoter constructs used for the expression and transcription constructs also contain other DNA sequences, such as enhancers and 3' termination sequences. Such sequences are well known in the art.
- the cloned construct is then inserted into a plasmid or other vector suitable for transformation.
- Maize type II friable callus suitable for transformation and regeneration is cultured using known techniques (Green, L.E. et al. 1975. "Plant Regeneration From Tissue Cultures of Maize.” Crop Science 15:417-421 and Vasil, V. et al. 1984. "Somatic Embryogenesis in Long-term Callus Cultures of Zea mays L. (Gramineae)" ⁇ mer. J. Bot. 71:158-61, both of which are incorporated herein by reference). Cells are transformed using the ballistic technique, detailed below in the Examples. Putative transformants are regenerated into intact plants.
- the plants which have been transformed with a developmentally delayed promoter construct are grown to maturity and are seen to bear supersweet corn which later (approximately 25-30 dpp) becomes starchy.
- the progeny of these plants (either inbred or the result of a cross with a non-related, transformed or non-transformed plant) also bear supersweet corn which ages into starchy corn. All of these progeny plants are included within the invention.
- Polysomes are isolated according to the methods of Larkins et al. 1976 "Isolation and in Vitro Translation of Zein Messenger Ribonucleic Acid” Bioche 75 (25).: 5586, Larkins et al. 1976. "Storage Protein Synthesis in Maize” Plant Physiol 57:740-745, and Larkins et al. 1978. "Synthesis and Deposition of Zein in Protein Bodies of Maize Endosperm” Plant Physiol. 62:256-263, which are hereby incorporated by reference.
- Isolated polysomes are resuspended in 1% w/v triisopropylnaphthalene-sulfonic acid, Na salt; 6% w/v p-amino-salicylic acid; 0.1 M TRIS-HC1, pH 7.6; 50 mM EGTA; 0.1 M NaCl; 1% w/v SDS; and 50 mM 2-mercaptoethanol (Rochester et al. 1986. EMBO J. 5:451-458). An equal volume of phenol/chloroform/isoamyl alcohol (25/24/1) is added. After centrifugation, the supernatant fluid is removed to a new tube and re-extracted.
- cDNA clones for Sh-2 and Bt-2 are isolated as reported by Bhave et al., 1990, "Identification and Molecular Characterization of Shrunken-2 cDNA Clones of Maize” The Plant Cell 2:581-588, and Bae et al., 1990, Maydica 35:317-322, both of which are incorporated by reference.
- a genomic library from public maize line W22 is made in Lambda EMBL3 according to standard procedures as described in Ausubel et al. 1987. Current Protocols in Biology, Wiley Interscience.
- Approximately 5 X 10 6 clones are transferred to nitrocellulose and are screened using the radiolabelled cDNAs as probes, in 5X SSC, 0.1% SDS, IX Denhardt's solution, 50% formamide and 42°C for hybridization. Filters are washed four times for 30 minutes at 65°C in 0.1X SSC and 0.1% SDS.
- Genomic clones isolated in this way are mapped first using Lambda Map (Promega). The rough map generated is then refined using conventional mapping techniques of probing Southern blots of various restriction digests of the clones. Maps thus generated are shown in Figures 5-6.
- Subcloning of the genomic clones is done with pT7T3 vectors (Pharmacia). Nested deletions are performed with a commercial kit according to the directions of the manufacturer (Pharmacia). Sequencing is done by the dideoxy chain termination method using T7 polymerase (Pharmacia). Sequences of the Sh-2 genomic clone is given in TABLE 1 (SEQ.ID N0:1).
- GST glutathione-S-transferase
- Rabbits are immunized with 650-850 ⁇ g of either of the purified proteins in complete Freund's adjuvant and boosted every other week with 250 ⁇ g of protein in incomplete Freund's adjuvant. Anti-Bt-2 and Anti-Sh-2 sera is obtained.
- Modified subtractive cDNA libraries are made using the procedure of Timblin et al.(1990 Nucl. Acids Res. 18(6).-1587-1593) which is hereby incorporated by reference.
- mRNA populations are isolated 15, 25, and 35 dpp. Double stranded cDNAs from these populations are made blunt and linkers are added. The linkers are chosen so as to serve as a Polymerase Chain Reaction (PCR) oligomer binding site.
- the resulting cDNAs are amplified according to the manufacturer's recommended instructions and are also used as probes.
- Clones are identified which show differences (either quantitative or qualitative) in the mRNA populations. These represent potential developmentally delayed promoters. The copy numbers of these clones are determined using standard protocols, and those with a low copy number ( ⁇ 5 copies per genome) are selected. These are used for in situ hybridization to maize endosperm sections to determine which are active in appropriate cell layers.
- genes are isolated from a maize genomic library. Promoter regions are isolated using conventional techniques. Putative promoters are tested by constructing b-glucuronidase (GUS) fusions, delivering the hybrid construct to longitudinal endosperm sections via the ballistic particle delivery process and visually determining their activity by GUS staining (Jefferson, R.A. 1988. in Genetic Engineering, Principles and Methods, Vol. 10:247-263 J.K. Setlow, Ed.) The promoters resulting from this isolation and evaluation are designated Promoter 20, which maximizes mRNA synthesis at approximately 20 dpp and Promoter 30 which maximizes mRNA synthesis at approximately 30 dpp. These are used to make transformation vectors, discussed in Example 7, below.
- GUS b-glucuronidase
- Example 4 The procedure of Example 4 is repeated, using polysomal RNA. The same developmentally delayed promoters are identified.
- Promoter 20 from Example 5 is linked to the Sh-2 gene, along with the Sh-2 gene endogenous terminator. This construct is referred to as the agronomic cassette-20.
- a similar cassette is constructed using Promoter 3C linked to the Bt-2 gene and terminator, referred to as agronomic cassette-30.
- the vectors used for maize callus transformation are pUC19 derivatives a bacterial selectable marker ( ⁇ -lactamase, i.e. ampicillin/carbenicillin resistance) and a maize selectable marker.
- the maize selectable marker has the cauliflower mosaic virus 35S promoter, a portion of intervening sequence II from maize alcohol dehydrogenase, and a selectable gene: neomycin phosphotransferase II (i.e. kanamycin resistance) or phosphinothricin acetyltransferase (i.e. resistance to the herbicides Basta and Bialophos) or acetolactate synthase (i.e. resistance to the herbicide chlorsulfuron).
- the selectable gene sequence is followed by the nopalene synthase terminator.
- agronomic cassette-20 is inserted using standard techniques into the above vector to create pSh-2.
- agronomic cassette-30 is inserted into the vector to create pBt-2.
- E. coli are transformed with either plasmid using standard techniques (Ausabel et al. , supra).
- 1.5 mm embryos (10-13 dpp) from 29 sh-2 lines are explanted and placed on initiation medium (either Murashige-Skoog with 1.5 mg/1 Dicamba or N6 with 1 mg/1 2,4-D). Callus is transferred to and maintained on N6 containing 6 mM asparagine, 12 mM proline and 1 mg/12,4-D. Friable callus is selected and is used in the transformation procedure, below.
- Plasmid pSh-2 is introduced into Type II maize callus of a sh-2 supersweet corn line using a ballistic process. Plants are regenerated following known procedures and are self-pollinated. ADP-GPP activity is determined prior to 20 dpp and after 30 dpp to ascertain the induction of Sh-2 transcription and its subsequent translation. Plants are then evaluated for agronomic performance, and those with the desired phenotype are identified.
- Plasmid pBt-2 is introduced into Type II maize callus of a bt-2 line using a ballistic process. Plants are regenerated following known procedures and are self-pollinated. ADP-GPP activity is determined prior to 20 dpp and af er 30 dpp to ascertain the induction of Bt-2 transcription and translation. Plants are then evaluated for agronomic performance, and those with the desired phenotype are selected.
- EXAMPLE 9 INDUCIBLE PROMOTER CONSTRUCTS
- Vectors for callus transformation are constructed similarly to those described in Example 6, except for the agronomic cassettes.
- the agronomic cassette contains the promoter which is inducible by the 20-hydroxyecdysone binding protein binary complex operably linked to either the Sh-2 gene or Bt-2 gene and their respective endogenous terminators.
- the plasmid containing the inducible Sh-2 construct is designated pISh-2.
- the plasmid containing the inducible Bt-2 construct is designated pIBt-2.
- Maize calli are co-transformed with either pISh-2 and pRecept or pIBt-2 and pRecept.
- pRecept is a compatible plasmid which codes for expression of the 20-hydroxyecdysone receptor. Transformants carrying both heterologous gene constructs are selected and regenerated into plants which inducibly express either Sh-2 or Bt-2.
- Construct 1110 contains the 35S promoter, the maize IVS6 intron, EcRB gene construct and the Nos terminator.
- Construct 1112 comprises the Steroid Response Element (SRE) linked to the -46 35S promoter fragment (base pairs -46 to +1), the maize IVS6 intron, GUS gene and the NOS terminator.
- SRE Steroid Response Element
- Construct 1113 comprises the SRE (as above) linked to a maize promoter, the IVS6 intron, the gene and the NOS terminator.
- Black Mexican Sweet (BMS) suspension cells are transformed with the above constructs using the ballistic technique, incubated overnight, and then are overlaid with X-gluc staining solution which may contain 1 ⁇ M of the phytoecdysteroid Ponasterone A (PNA), as indicated below. Three plates are transformed for each construct. Results are presented below.
- PNA phytoecdysteroid Ponasterone A
- the ethanol phase is then concentrated in a vacuum and partitioned between methylene chloride: ethanol: water (2 ml each phase), and the methylene chloride phase is then concentrated to dryness.
- This is dissolved in ethyl acetate: ethanol (2:1) as a 5% solution and filtered through neutral alumina (10% H 2 0, 2 g) and is eluted with further solvent (25 ml).
- the total eluate is evaporated to dryness.
- the crude ecdysteroids are then dissolved in methylene chloride: ethanol (2:1 to make a 5% solution w/v) and an aliquot is transferred to a TLC plate for purification.
- the fractions are tested for ecdysone agonist activity by incubation with a genetically engineered Drosophila cell line which is ecdysone responsive. No ecdysone activity is observed in either the sweet corn endosperm or BMS cell extracts, with a limit of detection ⁇ 20 ng 20-0H-ecdysone equivalents/g. Hexane (lipophilic) and aqueous/ethanol (polar) fractions are also investigated for ecdysone agonist activity since transfection assays with the insect ecdysone receptor/hormone response element genes incorporated into BMS cells have indicated an endogenous supply of ecdysone agonist positive substance.
- the lipophilic and polar fractions are assayed in the ecdysone responsive cell line. No activity is observed, but some toxicity is noted in the concentrated polar samples. However, it can be calculated that the level of 20-OH-ecdysone equivalents is ⁇ 200 ng/g endosperm or ⁇ 100 ng/g BMS cells, and may be much less.
- Three dosages of 322-843 are prepared: 0, 20 mg and 200 mg active ingredient per plant.
- 100 ml dimethylsulfoxide (DMSO) is added to 20 liters of water in a clean container and is mixed thoroughly.
- Four liters are applied to each plant a 1, 7, or 14 days post pollination.
- Each plant is in a 5 gallon container fitted with a base to catch leachate so that the leachate can be reabsorbed into the soil.
- 20 mg dose the same procedures are followed except that 0.1 g 322-843 is dissolved in the 100 ml DMSO.
- 1.0 g of 322-843 is dissolved in the DMSO. Regardless of the dose, all solutions are prepared just prior to use. Ears are harvested 16 days post-pollination and are frozen in liquid nitrogen.
- Three dosages of 322-843 (0, 20, and 200 mg active ingredient per plant) are prepared as below just prior to application at 1, 7, or 14 days post pollination. Ears are harvested at 16 days post-pollination and are frozen in liquid nitrogen. For 0 mg, 2.5 g Valent X-77 is dissolved in 500 ml acetone to make a 0.5% solution. 100 ml of this solution is mixed with 100 ml water. 40 ml of the solution are sprayed per plant. For 20 mg, 0.1 g 322-843 is dissolved in 100 ml of the 0.5% Valent X-77/acetone solution and then mixed with 100ml water. 40 ml are sprayed per plant. For 200 mg, 1.0 g 322-843 is dissolved in 100 ml of the 0.5% Valent X-77/acetone solution and mixed with 100 ml water. 40 ml are sprayed per plant.
- Endosperm from plants treated by the soil drench or foliar spray is analyzed as follows. For a standard, 10 ⁇ l of a CH 3 CN solution of [14C]322-843 containing approximately 25,000 dpm (approximately 30 ng) is dispensed into 25 ml methanol in a 50 ml beaker. 3 g of heat-treated celite and 5 g of thawed endosperm are added, and then chilled over ice. (The blank does not contain any corn tissue). The corn tissue is homogenized, and the homogenate is filtered under a vacuum. The filter cake is returned to the original flask and 25 ml dichloromethane is added, and the procedure is repeated.
- the solvent is then removed under a vacuum and mild heat, leaving an oily residue.
- the residue is dissolved in 1-2 ml dichloromethane and water.
- the solvent layer is removed, and the contents are extracted with 2 x 100 ⁇ l of acetonitrile and then dried.
- the acetonitrile extract is re-dissolved in 50 ⁇ l dichloromethane and vortexed.
- a sample is added to a silica GF TLC plate (1000 ⁇ l thick layer) which is predeveloped with methanol and air dried for 24 hours.
- the solvent is evaporated from the plate and plates are developed in 3% methanol/97% dichloromethane. Plates are air-dried and scanned with a radioactivity monitor.
- the radioactive zone is transferred to a fritted funnel and the 322-843 is eluted with acetonitrile under a slight vacuum.
- the sample is redissolved in acetonitrile for quantification of recovery and subsequent HPLC analysis. Alternatively, it is redissolved in 50 ⁇ l DMSO for screening in the Drosophila ecdysone agonist insect cell line assay or HPLC analysis.
- HPLC analysis is performed using a 25 x 0.46 cm Spheri-5 RP-8 column and a linear gradient system: initially 40% acetonitrile in 0.01 TFA and, after 20 minutes 90% acetonitrile in 0.01% TFA, with a 5 min hold at 90% acetonitrile and a 5 min return to starting conditions.
- the flow rate of solvent is 1.5 ml/min.
- RT for 322-843 is approximately 7.6 min.
- the 322-843 zone is collected for liquid scintillation counting and the UV peak area (255 nm) is integrated. After correcting for 100% recovery of the radiolabelled internal standard, total mass of 322-843 is calculated. Additional HPLC using a normal phase system was also utilised in further analysis of the samples.
- a soil application at 200 mg is suffucient for uptake of 322-843 and transport to endosperm in quantities sufficient for inducible activity.
- constructs are made using conventional cloning techniques and are tested for endosperm activity using a GUS reporter gene. The number of blue stains were counted and the results obtained are given below for the constructs tested.
- MOLECULE TYPE DNA (genomic)
- HYPOTHETICAL NO
- ANTI-SENSE NO
- CGGCCGGGAC CAATGTTCTG GTCTCTTCTT AATATAATAC CGGG ⁇ CAGTC TTTCCCTCTC 540
- TTTTTTCAAC AAATAATGTG GTGAAATACC TAAGAGGGGT GCACCTAGCA TAGATTTTTT 900
- AAAGGTATAA ACCACGGCTG TGCATTTTGG AAGTATCATC TATAGATGTC TGTTGAGGGG 1320
- CTATGGACTT CTACCATTTA TGTTATTACT TTGCCTTAAT GTTCCATTGA ATAGGGCAAA 3960
- CAAGCATCAC CAAATCACAC AGAACAATAG CAACAAAGCC TTTTAGTTCC AAGCAATTTA 5880
- ATATAATCCT ATTCTAATCG AGAAGTCATC TGTATCTTCG TCTCTTGTTC GAACACTAGT 7080 CACAAATTTT TTTGTACATG TTCTTAATGA GTCCAACGTA ATATTCCTTG ATATTTTGTC 714
- ATAAGCCCTC ATCAAGTCAA TGAAAATCGC GTGTAGGTCC TTCATTTGTT CCTTATACTG 720
- GGTAGTGCCC TAAATAAATT TTAGTTCAAA AATGAATAAA AAT ⁇ TGGCTG ATTCTAACTT 9780
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Glass Compositions (AREA)
- Organic Insulating Materials (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9401302A HU219313B (en) | 1991-11-05 | 1992-11-04 | Improved supersweet corn; transformation method and tools; growing method |
EP92923267A EP0611395A1 (fr) | 1991-11-05 | 1992-11-04 | Mais tres sucre et ameliore |
JP5508166A JPH07500965A (ja) | 1991-11-05 | 1992-11-04 | 改良超甘味トウモロコシ |
AU29203/92A AU670417B2 (en) | 1991-11-05 | 1992-11-04 | Improved supersweet corn |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79193391A | 1991-11-05 | 1991-11-05 | |
US791,933 | 1991-11-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993009237A1 true WO1993009237A1 (fr) | 1993-05-13 |
Family
ID=25155266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1992/002531 WO1993009237A1 (fr) | 1991-11-05 | 1992-11-04 | Mais tres sucre et ameliore |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0611395A1 (fr) |
JP (1) | JPH07500965A (fr) |
AU (1) | AU670417B2 (fr) |
HU (1) | HU219313B (fr) |
IL (1) | IL103647A (fr) |
WO (1) | WO1993009237A1 (fr) |
ZA (1) | ZA928538B (fr) |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993021334A1 (fr) * | 1992-04-13 | 1993-10-28 | Zeneca Limited | Produits de recombinaison d'adn et plantes les incorporant |
WO1994009144A1 (fr) * | 1992-10-14 | 1994-04-28 | Zeneca Limited | Nouvelles plantes et leurs procedes d'obtention |
WO1994011520A3 (fr) * | 1992-11-09 | 1994-08-04 | Zeneca Ltd | Nouvelles plantes et procedes de production |
EP0634491A1 (fr) * | 1993-07-12 | 1995-01-18 | Monsanto Company | Semences à contenu en huile modifiée |
WO1994028146A3 (fr) * | 1993-05-24 | 1995-01-26 | Hoechst Schering Agrevo Gmbh | Sequences d'adn et plasmides destines a la production d'une betterave a concentration de sucre modifiee |
WO1995034660A1 (fr) * | 1994-06-16 | 1995-12-21 | Advanced Technologies (Cambridge) Limited | Modification de la teneur en amidon de plantes |
US5498831A (en) * | 1993-07-23 | 1996-03-12 | Dna Plant Technology Corporation | Pea ADP-glucose pyrophosphorylase subunit genes and their uses |
WO1996027673A1 (fr) * | 1995-03-03 | 1996-09-12 | Novartis Ag | Regulation de l'expression genique dans les plantes par transactivation induite par recepteur en presence d'un ligand chimique |
WO1997013864A1 (fr) * | 1995-10-10 | 1997-04-17 | Novartis Ag | Hormone juvenile ou l'un de ses agonistes utilises en tant que ligand chimique aux fins de reguler l'expression genique dans des plantes, a l'aide d'une transactivation induite par des recepteurs |
WO1997026365A3 (fr) * | 1996-01-19 | 1997-09-12 | Dekalb Genetic Corp | Mais transgenique a teneur accrue en mannitol |
WO1998005785A1 (fr) * | 1996-08-01 | 1998-02-12 | Biocem | Phytases de plantes et applications biotechnologiques |
US5866790A (en) * | 1993-05-24 | 1999-02-02 | Hoechst Schering Agrevo Gmbh | DNA sequences and plasmids for the preparation of sugar beet with changed sucrose concentration |
US6013861A (en) * | 1989-05-26 | 2000-01-11 | Zeneca Limited | Plants and processes for obtaining them |
WO2000012733A1 (fr) * | 1998-08-28 | 2000-03-09 | Pioneer Hi-Bred International, Inc. | PROMOTEURS PREFERES DE SEMENCES PROVENANT DE GENES $i(END) |
US6057493A (en) * | 1990-04-20 | 2000-05-02 | Hoechst Schering Agrevo Gmbh | Plasmids, plants and plant cells expressing anti-sense patatin and anti-sense ADP-glucose pyrophosphorylase sequences |
WO2000029597A3 (fr) * | 1998-11-19 | 2000-11-09 | Univ Florida | Genes mutants codant pour l'adp-glucose pyrophosphorylase chez des vegetaux |
WO2000078984A3 (fr) * | 1999-06-21 | 2001-02-15 | Pioneer Hi Bred Int | Amelioration de la resistance de puits florale et augmentation de la stabilite de grenaison des plantes |
FR2799203A1 (fr) * | 1999-10-01 | 2001-04-06 | Biogemma Fr | Promoteurs specifiques de l'albumen des graines de vegetaux |
US6379945B1 (en) | 1995-05-26 | 2002-04-30 | Zeneca Limited | Gene switch |
FR2818286A1 (fr) * | 2000-12-19 | 2002-06-21 | Agronomique Inst Nat Rech | Acides nucleiques et polypeptides exprimes specifiquement dans les cellules de la zone de transfert d'un grain de plante et leurs applications |
US6610828B1 (en) | 1996-05-24 | 2003-08-26 | Syngenta Limited | Heliothis ecdysone receptor |
WO2002036788A3 (fr) * | 2000-11-06 | 2003-09-25 | Agronomique Inst Nat Rech | Acides nucleiques et polypeptides exprimes specifiquement dans les cellules de la zone de transfert d'un grain de plante et leurs applications |
US6960709B1 (en) | 1993-08-25 | 2005-11-01 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US7064248B2 (en) | 1990-01-22 | 2006-06-20 | Dekalb Genetics Corp. | Method of preparing fertile transgenic corn plants by microprojectile bombardment |
US7285703B2 (en) | 1998-04-03 | 2007-10-23 | Basf Plant Science Gmbh | Plant like starches and the method of making them in hosts |
US7288403B2 (en) | 1993-08-25 | 2007-10-30 | Anderson Paul C | Anthranilate synthase gene and method for increasing tryptophan production |
US7615685B2 (en) | 1990-01-22 | 2009-11-10 | Dekalb Genetics Corporation | Methods of producing human or animal food from stably transformed, fertile maize plants |
US8030540B2 (en) | 2004-04-21 | 2011-10-04 | Basf Plant Science Gmbh | Transgenic corn having enhanced nutritional qualities |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990000856A1 (fr) * | 1988-07-21 | 1990-02-08 | Dna Plant Technology Corporation | Produit hybride de mais a grand rendement |
EP0368506A2 (fr) * | 1988-11-10 | 1990-05-16 | Zeneca Limited | ADP glucose-pyrophosphorylase |
-
1992
- 1992-11-04 EP EP92923267A patent/EP0611395A1/fr not_active Ceased
- 1992-11-04 AU AU29203/92A patent/AU670417B2/en not_active Ceased
- 1992-11-04 HU HU9401302A patent/HU219313B/hu not_active IP Right Cessation
- 1992-11-04 WO PCT/EP1992/002531 patent/WO1993009237A1/fr not_active Application Discontinuation
- 1992-11-04 JP JP5508166A patent/JPH07500965A/ja active Pending
- 1992-11-05 IL IL10364792A patent/IL103647A/xx not_active IP Right Cessation
- 1992-11-05 ZA ZA928538A patent/ZA928538B/xx unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990000856A1 (fr) * | 1988-07-21 | 1990-02-08 | Dna Plant Technology Corporation | Produit hybride de mais a grand rendement |
EP0368506A2 (fr) * | 1988-11-10 | 1990-05-16 | Zeneca Limited | ADP glucose-pyrophosphorylase |
Non-Patent Citations (7)
Title |
---|
BIOTECHNOLOGY vol. 10, no. 1, 1992, NEW YORK US pages 40 - 43 FRALEY, R. 'Sustaining the food supply' * |
CHEMICAL ABSTRACTS, vol. 115, 1991, Columbus, Ohio, US; abstract no. 249560, SONNEWALD, U., ET AL. 'Expression vectors for manipulation of protein or carbohydrate content of potato tubers' * |
GENE vol. 97, no. 2, 15 January 1991, AMSTERDAM NL pages 199 - 205 ANDERSON, J.M., ET AL. 'Molecular characterization of the gene encoding a rice endosperm-specific ADPglucose pyrophosphorylase subunit and its developmental pattern of transcription' * |
PLANT PHYSIOLOGY. vol. 92, 1990, ROCKVILLE, MD, USA. pages 881 - 885 PREISS, J., ET AL. 'Molecular characterization of the Brittle-2 gene effect on maize endosperm ADPglucose pyrophosphorylase subunits' * |
PLANT PHYSIOLOGY. vol. 98, 1992, ROCKVILLE, MD, USA. pages 1214 - 1216 SHAW, J.R., ET AL. 'Genomic nucleotide sequence of the wild-type Shrunken-2 allele of Zea mays' * |
See also references of EP0611395A1 * |
THE PLANT CELL. vol. 2, no. 6, June 1990, ROCKVILLE, MD, USA. pages 581 - 588 BHAVE , M.R., ET AL. 'Identification and molecular characterization of Shrunken-2 cDNA clones of maize' * |
Cited By (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6013861A (en) * | 1989-05-26 | 2000-01-11 | Zeneca Limited | Plants and processes for obtaining them |
US7064248B2 (en) | 1990-01-22 | 2006-06-20 | Dekalb Genetics Corp. | Method of preparing fertile transgenic corn plants by microprojectile bombardment |
US7615685B2 (en) | 1990-01-22 | 2009-11-10 | Dekalb Genetics Corporation | Methods of producing human or animal food from stably transformed, fertile maize plants |
US6057493A (en) * | 1990-04-20 | 2000-05-02 | Hoechst Schering Agrevo Gmbh | Plasmids, plants and plant cells expressing anti-sense patatin and anti-sense ADP-glucose pyrophosphorylase sequences |
US6605754B1 (en) | 1992-04-13 | 2003-08-12 | Syngenta Limited | DNA constructs and plants incorporating them |
WO1993021334A1 (fr) * | 1992-04-13 | 1993-10-28 | Zeneca Limited | Produits de recombinaison d'adn et plantes les incorporant |
WO1994009144A1 (fr) * | 1992-10-14 | 1994-04-28 | Zeneca Limited | Nouvelles plantes et leurs procedes d'obtention |
WO1994011520A3 (fr) * | 1992-11-09 | 1994-08-04 | Zeneca Ltd | Nouvelles plantes et procedes de production |
WO1994028146A3 (fr) * | 1993-05-24 | 1995-01-26 | Hoechst Schering Agrevo Gmbh | Sequences d'adn et plasmides destines a la production d'une betterave a concentration de sucre modifiee |
US5866790A (en) * | 1993-05-24 | 1999-02-02 | Hoechst Schering Agrevo Gmbh | DNA sequences and plasmids for the preparation of sugar beet with changed sucrose concentration |
EP0634491A1 (fr) * | 1993-07-12 | 1995-01-18 | Monsanto Company | Semences à contenu en huile modifiée |
US5773693A (en) * | 1993-07-23 | 1998-06-30 | Dnap Plant Technology Corporation | Pea ADP-glucose pyrophosphorylase subunit genes and their uses |
US5498831A (en) * | 1993-07-23 | 1996-03-12 | Dna Plant Technology Corporation | Pea ADP-glucose pyrophosphorylase subunit genes and their uses |
US7288403B2 (en) | 1993-08-25 | 2007-10-30 | Anderson Paul C | Anthranilate synthase gene and method for increasing tryptophan production |
US7547820B2 (en) | 1993-08-25 | 2009-06-16 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US6960709B1 (en) | 1993-08-25 | 2005-11-01 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US6096945A (en) * | 1994-06-16 | 2000-08-01 | Advanced Technologies (Cambridge) Limited | Modification of starch content in plants |
US6486383B1 (en) * | 1994-06-16 | 2002-11-26 | Advanced Technologies (Cambridge) Limited | Modification of starch content in plants |
WO1995034660A1 (fr) * | 1994-06-16 | 1995-12-21 | Advanced Technologies (Cambridge) Limited | Modification de la teneur en amidon de plantes |
AU711602B2 (en) * | 1994-06-16 | 1999-10-14 | British American Tobacco (Investments) Limited | Modification of starch content in plants |
WO1996027673A1 (fr) * | 1995-03-03 | 1996-09-12 | Novartis Ag | Regulation de l'expression genique dans les plantes par transactivation induite par recepteur en presence d'un ligand chimique |
US6147282A (en) * | 1995-03-03 | 2000-11-14 | Novartis Finance Corporation | Method of controlling the fertility of a plant |
US6939711B2 (en) | 1995-03-03 | 2005-09-06 | Syngenta Investment Corporation | Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
US5880333A (en) * | 1995-03-03 | 1999-03-09 | Novartis Finance Corporation | Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
US6379945B1 (en) | 1995-05-26 | 2002-04-30 | Zeneca Limited | Gene switch |
WO1997013864A1 (fr) * | 1995-10-10 | 1997-04-17 | Novartis Ag | Hormone juvenile ou l'un de ses agonistes utilises en tant que ligand chimique aux fins de reguler l'expression genique dans des plantes, a l'aide d'une transactivation induite par des recepteurs |
US6362394B1 (en) | 1995-10-10 | 2002-03-26 | Syngenta Participations Ag | Juvenile hormone or one of its agonists as a chemical ligand to control gene expression in plants by receptor mediated transactivation |
EA003423B1 (ru) * | 1995-10-10 | 2003-04-24 | Новартис Аг | Штамм трансгенных растительных клеток и трансгенное растение, содержащие кассету экспрессии полипептида-мишени usp рецептора, способы получения их потомства, способы регулирования экспрессии полипептида-мишени в указанном растении с помощью ювенильного гормона или его агонистов, способы выявления и получения лиганда для полипептида usp рецептора и соответствующий лиганд |
WO1997026365A3 (fr) * | 1996-01-19 | 1997-09-12 | Dekalb Genetic Corp | Mais transgenique a teneur accrue en mannitol |
US6610828B1 (en) | 1996-05-24 | 2003-08-26 | Syngenta Limited | Heliothis ecdysone receptor |
US7183061B2 (en) | 1996-05-24 | 2007-02-27 | Syngenta Limited | Method of expressing Heliothis ecdysone receptor fusion protein |
WO1998005785A1 (fr) * | 1996-08-01 | 1998-02-12 | Biocem | Phytases de plantes et applications biotechnologiques |
US7285703B2 (en) | 1998-04-03 | 2007-10-23 | Basf Plant Science Gmbh | Plant like starches and the method of making them in hosts |
US6528704B1 (en) | 1998-08-28 | 2003-03-04 | Pioneer Hi-Bred International, Inc. | Seed-preferred promoters from end genes |
WO2000012733A1 (fr) * | 1998-08-28 | 2000-03-09 | Pioneer Hi-Bred International, Inc. | PROMOTEURS PREFERES DE SEMENCES PROVENANT DE GENES $i(END) |
US6184438B1 (en) | 1998-11-19 | 2001-02-06 | University Of Florida | Mutant genes encoding plant ADP-glucose pyrophosphorylase and methods of use |
WO2000029597A3 (fr) * | 1998-11-19 | 2000-11-09 | Univ Florida | Genes mutants codant pour l'adp-glucose pyrophosphorylase chez des vegetaux |
WO2000078984A3 (fr) * | 1999-06-21 | 2001-02-15 | Pioneer Hi Bred Int | Amelioration de la resistance de puits florale et augmentation de la stabilite de grenaison des plantes |
US7193130B2 (en) | 1999-06-21 | 2007-03-20 | Pioneer Hi-Bred International, Inc. | Expressing acid invertase or ADP-glucose pyrophosphorylase in floral tissue for enhanced floral sink strength and increased stability of seed in plants |
US8026411B2 (en) | 1999-06-21 | 2011-09-27 | Pioneer Hi-Bred International, Inc. | Enhanced floral sink strength and increased stability of seed set in plants |
US7071378B1 (en) | 1999-10-01 | 2006-07-04 | Biogemma | Plant seed endosperm specific promoter |
WO2001025439A1 (fr) * | 1999-10-01 | 2001-04-12 | Biogemma | Promoteurs specifiques de l'albumen des graines de vegetaux |
FR2799203A1 (fr) * | 1999-10-01 | 2001-04-06 | Biogemma Fr | Promoteurs specifiques de l'albumen des graines de vegetaux |
WO2002036788A3 (fr) * | 2000-11-06 | 2003-09-25 | Agronomique Inst Nat Rech | Acides nucleiques et polypeptides exprimes specifiquement dans les cellules de la zone de transfert d'un grain de plante et leurs applications |
FR2818286A1 (fr) * | 2000-12-19 | 2002-06-21 | Agronomique Inst Nat Rech | Acides nucleiques et polypeptides exprimes specifiquement dans les cellules de la zone de transfert d'un grain de plante et leurs applications |
US8030540B2 (en) | 2004-04-21 | 2011-10-04 | Basf Plant Science Gmbh | Transgenic corn having enhanced nutritional qualities |
Also Published As
Publication number | Publication date |
---|---|
HU219313B (en) | 2001-03-28 |
HU9401302D0 (en) | 1994-08-29 |
ZA928538B (en) | 1994-05-05 |
AU670417B2 (en) | 1996-07-18 |
IL103647A (en) | 2000-06-01 |
HUT66207A (en) | 1994-10-28 |
AU2920392A (en) | 1993-06-07 |
IL103647A0 (en) | 1993-04-04 |
EP0611395A1 (fr) | 1994-08-24 |
JPH07500965A (ja) | 1995-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU670417B2 (en) | Improved supersweet corn | |
KR100452853B1 (ko) | 저온유도성프로모터서열 | |
US5859333A (en) | Plants and processes for obtaining them | |
Ainsworth et al. | Adenosine diphosphate glucose pyrophosphorylase genes in wheat: differential expression and gene mapping | |
US6680429B1 (en) | Starchless variety of pisum sativum having elevated levels of sucrose | |
Radwanski et al. | Characterization of tryptophan synthase alpha subunit mutants of Arabidopsis thaliana | |
US5959180A (en) | DNA sequences from potato encoding solanidine UDP-glucose glucosyltransferase and use to reduce glycoalkaloids in solanaceous plants | |
WO1993008682A1 (fr) | Procedes d'obtention de graines de mais a haute teneur en methionine, et leurs utilisations | |
AU765277B2 (en) | Plant photoperiod sensitivity gene Hd1 and use of the same | |
CA2323756C (fr) | Genie genetique de l'halotolerance dans les plantes cultivees | |
US6127532A (en) | Lectin cDNA and transgenic plants derived therefrom | |
JP2002523052A (ja) | ポリヌクレオチド配列 | |
Byrne et al. | Half-lives of oat mRNAs in vivo and in a polysome-based in-vitro system | |
US6177614B1 (en) | Control of floral induction in plants and uses therefor | |
US6700039B1 (en) | Genetic method for controlling sprouting | |
KR100455621B1 (ko) | 화분 특이적 징크 핑거 전사 인자 유전자의 사용에 의한화분 임성의 저하방법 | |
US20020133850A1 (en) | Melon promoters for expression of transgenes in plants | |
AU727951B2 (en) | Method of changing the composition of the phospholipid produced by the living body and recombinant vector therefor | |
CA2193084A1 (fr) | Genes de plantes affectant la biosynthese de l'acide gibberellique | |
US6271440B1 (en) | Plant regulatory proteins III | |
US7074986B1 (en) | Construction of barley with reduced gel protein content | |
US7511191B1 (en) | Raffinose synthase genes and their use | |
US6831168B1 (en) | Aldehyde oxidase gene derived from plant and utilization thereof | |
AU741854B2 (en) | Control of floral induction in plants and uses therefor | |
US20020100074A1 (en) | Method for producing transformed plant having increased glutamic acid content |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU HU JP UA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) |
Free format text: UA |
|
LE32 | Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b) |
Ref country code: KZ |
|
LE32 | Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b) |
Ref country code: KZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1992923267 Country of ref document: EP |
|
EX32 | Extension under rule 32 effected after completion of technical preparation for international publication |
Ref country code: UZ |
|
LE32 | Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b) |
Ref country code: UZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1992923267 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1992923267 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992923267 Country of ref document: EP |